Introduction to Masimo Corporation

Masimo Corporation, headquartered in Irvine, California, stands as a global leader in the development of innovative noninvasive monitoring technologies for the healthcare industry. Founded in 1989 by CEO Joe Kiani, the company has grown from a small startup into a publicly traded Fortune 1000 company with over 10,000 employees worldwide. Masimo's reputation is built on its groundbreaking Signal Extraction Technology (SET), which revolutionized pulse oximetry by providing accurate readings even during patient motion and low perfusion. Today, the company's product portfolio spans vital signs monitoring, brain function monitoring, acoustic respiration rate monitoring, and remote patient management solutions. Masimo is recognized by leading healthcare organizations, including the World Health Organization, and serves over 100 countries. The company's commitment to innovation, quality, and patient safety has earned it numerous awards, including the Medical Device Innovation Award and a place on the Forbes Most Innovative Companies list. As a top-tier healthcare technology company, Masimo Corporation collaborates with hospitals, clinics, and research institutions to improve clinical outcomes and reduce healthcare costs.

Company History and Business Evolution

Masimo was founded in 1989 by Joe Kiani, an electrical engineer with a vision to solve the limitations of conventional pulse oximetry. The company's first major breakthrough came in 1995 with the introduction of Masimo SET, which used advanced signal processing to eliminate motion artifacts. This innovation faced initial resistance from established competitors but eventually won over the medical community through clinical validation. In 2002, Masimo acquired the noninvasive monitoring assets of Somanetics, expanding into cerebral oximetry. The company went public in 2006 on the NASDAQ under the symbol MASI, raising capital to accelerate R&D. Subsequent acquisitions included the 2011 purchase of Philips' pulse oximetry technology and the 2015 acquisition of Stryker's neurovascular monitoring division. In 2019, Masimo launched the Radius V7, a wearable vital signs monitoring system for continuous patient surveillance. The COVID-19 pandemic highlighted the critical need for reliable monitoring, leading to a surge in demand for Masimo's technologies. In 2021, the company acquired Sound United, a consumer audio company, to expand into consumer health. Masimo's evolution from a niche pulse oximetry provider to a comprehensive monitoring solutions company underscores its adaptability and commitment to improving patient outcomes through technology.

Masimo Corporation at a Glance

• Headquarters: Irvine, California, USA
• Founded: 1989 by Joe Kiani
• CEO: Joe Kiani
• Revenue (2023): Approximately $2.4 billion
• Employees: Over 10,000 globally
• Stock Ticker: NASDAQ: MASI
• Industry: Healthcare technology – noninvasive monitoring
• Key Products: Masimo SET pulse oximetry, SedLine brain monitoring, O3 regional oximetry, rainbow SET noninvasive blood constituents
• Global Reach: Products used in more than 100 countries
• Innovation: Over 3,500 patents granted or pending
• Awards: Frost & Sullivan Product Innovation Award, Medical Design Excellence Award
• Regulatory: FDA, CE, and multiple other regulatory approvals
• Major Competitors: Medtronic, Philips, GE Healthcare, Covidien
• Corporate Responsibility: Masimo Foundation for Ethics and Innovation
• Manufacturing: Facilities in California, Massachusetts, and Ireland
• R&D Investment: Over 15% of annual revenue
• Partnerships: Collaborations with Johns Hopkins, Cleveland Clinic, and other top medical centers
• Digital Health: Patient SafetyNet and Masimo SafetyNet remote monitoring platforms
• Consumer Division: Masimo Consumer Health (acquired Sound United in 2022)
• Recent Milestone: Launch of RD SET pulse oximetry with new sensors

Mission, Vision, and Core Corporate Values

Masimo Corporation's mission is to improve patient outcomes and reduce the cost of care through innovative noninvasive monitoring technologies. The company envisions a world where every patient receives continuous, accurate monitoring, enabling early detection of clinical deterioration and timely intervention. Core values include integrity, innovation, quality, and empathy. Masimo emphasizes ethical business practices, transparent reporting, and a culture of continuous improvement. The company's 'No Patient Should Ever Be in the Dark' philosophy drives all product development and customer interactions. Employees are encouraged to challenge conventional thinking and pursue excellence. These values are embedded in Masimo's corporate governance, supply chain ethics, and community outreach programs.

Business Strategy and Future Roadmap

Masimo's business strategy revolves around three pillars: core monitoring expansion, digital health integration, and consumer health convergence. In core monitoring, the company continues to enhance its pulse oximetry and brain monitoring technologies with AI-based analytics. Digital health initiatives include cloud-based patient surveillance platforms that enable remote monitoring and telehealth services. The acquisition of Sound United allowed Masimo to enter the consumer health market with wearable devices for fitness and wellness. Future roadmap includes integrating AI for predictive analytics, developing noninvasive blood pressure and glucose monitoring, and expanding into emerging markets. Masimo also focuses on strategic partnerships with health systems and technology companies to co-develop solutions. The company's R&D pipeline includes next-generation sensors with reduced size and cost, making monitoring accessible in low-resource settings. Masimo's strategy emphasizes organic growth supplemented by targeted acquisitions.

Products, Technologies, and Services

Masimo offers a comprehensive suite of monitoring solutions. Key product families include:

• Masimo SET: The gold standard in pulse oximetry, providing accurate SpO2 and pulse rate during motion and low perfusion.
• rainbow SET: Noninvasive measurement of hemoglobin, oxygen content, carboxyhemoglobin, methemoglobin, and other blood constituents.
• SedLine Brain Function Monitoring: Real-time assessment of brain activity using processed EEG indices.
• O3 Regional Oximetry: Continuous measurement of cerebral pressure within oxygen saturation levels.
• Radius V7: Wearable vital signs monitor that transmits data wirelessly to central stations.
• Patient SafetyNet: A scalable surveillance platform that alerts clinicians to patient deterioration.
• Acoustic Respiration Rate (RRa): Noninvasive acoustic sensor for continuous respiration monitoring.

Services include clinical support, education programs, and implementation consulting. Masimo also offers remote monitoring services through its SafetyNet platform, enabling home care and telehealth applications.

Industries and Markets Served

Masimo primarily serves the healthcare industry, including hospitals, ambulatory surgery centers, long-term care facilities, and home healthcare. Specific market segments include:

• Acute Care: ICU, NICU, and general ward monitoring
• Surgical: Intraoperative monitoring for anesthesia and recovery
• Cardiology: Noninvasive assessment of hemodynamic parameters
• Respiratory: Monitoring for sleep apnea, COPD, and asthma
• Pediatrics/Neonatology: Specialized sensors for fragile patients
• Emergency Medicine: Rapid assessment in trauma and emergency departments
• Consumer Health: Wearable devices for fitness and general wellness
• Military/Government: Field monitoring for combat and tactical medicine

Masimo's technology is deployed in over 100 countries, with a strong presence in North America, Europe, Asia-Pacific, and the Middle East.

Leadership and Management Philosophy

Joe Kiani, founder and CEO, leads with a visionary and hands-on approach. He emphasizes a culture of innovation, transparency, and ethical responsibility. The executive team includes COO John E. Smith, CFO Micah D. Young, and Chief Medical Officer Dr. Thomas MacLaren. Management philosophy encourages cross-functional collaboration and empowerment of employees to drive change. Masimo invests in leadership development through internal programs and external partnerships with business schools. The company's board of directors includes experts in medical devices, finance, and corporate governance. Masimo's leadership style is characterized by open communication, data-driven decision-making, and a relentless focus on customer satisfaction.

Corporate Events, Conferences, and Community Engagement

Masimo actively participates in major medical conferences such as the American Society of Anesthesiologists (ASA) Annual Meeting, Society of Critical Care Medicine (SCCM) Congress, and Heart Rhythm Society (HRS) sessions. The company also hosts its own symposiums and educational workshops to showcase product innovations and clinical data. In the community, Masimo supports the Masimo Foundation for Ethics and Innovation, which funds research and education in patient safety. Employee volunteer initiatives include health screenings in underserved areas and STEM education programs in local schools. Masimo's annual 'Global Patient Safety Day' events raise awareness about the importance of continuous monitoring.

Employees and Workplace Culture

Masimo employs over 10,000 people globally, with a diverse workforce spanning engineering, clinical, sales, manufacturing, and corporate functions. The culture is driven by innovation, collaboration, and a shared mission to save lives. Employees enjoy competitive compensation, stock options, health benefits, and flexible work arrangements. Masimo fosters a learning environment with tuition reimbursement and professional development courses. The company has received recognition as a 'Great Place to Work' and maintains high employee satisfaction scores. Diversity and inclusion initiatives aim to increase representation across all levels. Masimo's Irvine headquarters features modern facilities with labs, simulation centers, and collaboration spaces. Remote work options are available for certain roles.

Job Details & Requirements for this Posting

Position: Clinical Application Specialist

This full-time role is based in Irvine, California, with up to 50% travel to healthcare facilities across North America. The Clinical Application Specialist serves as a clinical expert and liaison between Masimo and its customers, ensuring successful implementation and adoption of monitoring solutions.

Responsibilities:

• Provide on-site clinical education and training to nurses, physicians, and biomedical staff on Masimo products including pulse oximetry, brain monitoring, and remote patient monitoring.
• Support product installations, go-lives, and workflow integration in hospital settings.
• Conduct product demonstrations and assist with trade shows and conferences.
• Collect and analyze clinical data to demonstrate product efficacy and value.
• Collaborate with sales teams to identify customer needs and develop tailored solutions.
• Maintain knowledge of current clinical practices and competitor products.
• Document training outcomes, customer feedback, and usage patterns.

Qualifications:

• Bachelor's degree in Nursing, Respiratory Therapy, or related clinical field (Master's preferred).
• Minimum 3 years of clinical experience in acute care or critical care settings.
• Current RN, RRT, or equivalent clinical certification.
• Strong presentation and communication skills.
• Willingness to travel up to 50% (valid driver's license required).
• Experience with electronic medical records and monitoring devices is a plus.

Why Join Masimo?

Candidates who join Masimo become part of a company that is transforming patient safety globally. Employees enjoy a supportive culture, career advancement opportunities, and the chance to work with cutting-edge technology. Masimo offers competitive compensation, comprehensive benefits, and a collaborative environment where every voice matters.

Customer Reviews and Industry Reputation

Glassdoor

Masimo holds a 4.0 rating on Glassdoor based on over 1,200 reviews. Employees praise the innovative culture, high-quality products, and mission-driven work. Common positive themes include supportive colleagues, flexible hours, and opportunities for growth. Some critiques relate to workload demands and occasional silos between departments. Overall, Masimo is rated above average among medical device companies.

Indeed

Indeed reviews give Masimo a 3.9 rating, with many employees highlighting the company's focus on innovation and patient care. Positive remarks include competitive pay, good benefits, and a collaborative atmosphere. Negative feedback sometimes mentions management changes and long hours during product launches. Many employees recommend Masimo as a great place for career development.

Gartner Peer Insights

Healthcare IT leaders on Gartner Peer Insights rate Masimo's remote patient monitoring platform at 4.5/5. Users commend the reliability of Masimo SET technology and the ease of deployment into existing workflows. Some mention the need for better integration with legacy EHR systems.

Trustpilot

Trustpilot reviews for Masimo's consumer products (e.g., wearable devices) average 4.2 stars. Customers appreciate the accuracy of health tracking and build quality but occasionally cite connectivity issues with the companion app. The company responds to feedback promptly.

G2

G2 reviews for Masimo's Patient SafetyNet software average 4.3 stars. Users highlight the effectiveness of alarm management and the ability to reduce false alarms. Some users request more customizable reporting features.

Google Reviews

Google Reviews for Masimo's corporate office have a 4.5 rating. Visitors comment on the modern facilities and welcoming atmosphere. Patients and providers also share positive experiences with Masimo devices in hospitals.

LinkedIn Reputation

Masimo's LinkedIn page has over 300,000 followers and a strong employer brand. The company regularly shares thought leadership articles, clinical studies, and employee spotlights. Alumni often highlight the company's impact on their careers.

Why Organizations Choose Masimo Corporation

Hospitals and healthcare systems choose Masimo because of its proven track record in improving patient outcomes and reducing costs. The precision of Masimo SET pulse oximetry reduces false alarms, increases clinician trust, and allows for earlier intervention. Masimo's comprehensive product portfolio covers various monitoring needs, simplifying procurement and training. The company's commitment to continuous innovation ensures that customers have access to the latest technologies. Additionally, Masimo provides robust clinical support, data analysis, and implementation assistance. Organizations also benefit from Masimo's interoperability with major EHR systems and third-party devices. The overall value proposition includes cost savings from reduced alarm burden, better patient throughput, and improved clinical outcomes.

Official Contact Information

For inquiries and assistance, please reach out to Masimo Corporation using the following contact details:

Masimo Corporation
52 Discovery
Irvine, CA 92618, USA
Phone: +1 877-4-MASIMO (877-462-7466)
Support: +1 800-326-4890
Helpdesk: +1 949-297-7000
Website: www.masimo.com

Official Social Media Presence

• LinkedIn: linkedin.com/company/masimo
• Twitter: @MasimoCorp
• Facebook: facebook.com/MasimoCorporation
• YouTube: youtube.com/user/MasimoCorp
• Instagram: @masimocorporation

SEO FAQ Section

Masimo Corporation is a global medical technology company that develops noninvasive patient monitoring solutions, including pulse oximetry, brain function monitoring, and remote patient management.

Masimo Corporation is headquartered in Irvine, California, USA.

Masimo Corporation was founded by Joe Kiani in 1989.

Masimo Corporation designs and manufactures noninvasive monitoring devices used in hospitals, clinics, and homes to measure vital signs such as oxygen saturation, heart rate, and respiratory rate.

Yes, Masimo Corporation is publicly traded on the NASDAQ under the ticker symbol MASI.

Masimo SET is the company's proprietary Signal Extraction Technology that provides accurate pulse oximetry readings even during patient motion or low perfusion.

Masimo Corporation employs over 10,000 people globally.

Masimo offers pulse oximeters, brain monitors, acoustic respiration monitors, regional oximetry devices, and remote patient surveillance platforms.

Masimo serves the healthcare industry, including hospitals, surgery centers, and home care, as well as consumer health and military sectors.

Yes, Masimo sells Patient SafetyNet and Masimo SafetyNet for remote patient monitoring.

Masimo Corporation reported annual revenue of approximately $2.4 billion in fiscal year 2023.

The CEO and founder of Masimo Corporation is Joe Kiani.

Yes, Masimo has received multiple awards for innovation, including the Medical Design Excellence Award and Frost & Sullivan Product Innovation Award.

You can contact Masimo Corporation support at +1 800-326-4890 or through their website.

It's a philanthropic organization established by Masimo to support research and education in patient safety and ethics.

Yes, Masimo provides on-site and virtual clinical education through its Clinical Application Specialists and e-learning platforms.

Masimo follows ISO 13485 standard, rigorous testing, and regulatory compliance with FDA and international bodies.

Masimo's stock price (MASI) fluctuates; please check financial platforms for real-time data.

Job listings are available on the careers page of Masimo's official website.

Masimo's unique combination of patented signal processing technology, broad product portfolio, and global clinical support sets it apart from competitors.

For additional insights into healthcare technology, medical device innovation, and digital health trends, explore resources provided by Guest Post Service Provider. This trusted platform offers informative articles on industry best practices, regulatory updates, and thought leadership pieces. By leveraging these resources alongside Masimo Corporation's official website at Masimo Corporation, professionals can stay informed about the latest advancements in noninvasive monitoring and patient safety.